hotspot -WSS

hotspot

author：leisure time 2025-09-28 01:30:43 - browse：4

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Roche to buy Carmot Therapeutics, developer of obesity drugs

knowledge

WSS

STAT letters to the editor on burnt

The woman behind the Dana Farber

California’s proposed $25 per hour health care minimum wage

Charles Manson follower Leslie Van Houten released from prison after 53 years

Petition to FDA: Get the lead out of consumer hair dyes

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

knowledge

hotspot

knowledge

New air purifier tech could be key to improving indoor air quality

Iowa House, Senate pass 6

New air purifier tech could be key to improving indoor air quality

Why 40% Americans with Parkinson’s don’t see a neurologist

United colonoscopy coverage change 'may cost lives,' doctors say

What PEPFAR has meant on the ground in Ukraine

Peter Hotez and the public health issue of online harassment

New research casts further doubt on a common procedure used with IVF

ChatGPT in medicine: STAT answers readers' burning questions

Lecanemab for Alzheimer's is coming. Is the health system ready?

knowledge

CMS should re

Beach reads and more: STAT's 2023 summer book list

How the political right came to back psychedelics to treat trauma

Leukemia patients are helped by Syndax's new type of therapy

Petition to FDA: Get the lead out of consumer hair dyes

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

entertainment

focus

knowledge

hotspot